As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...

Red-backed shrikes fly thousands of kilometers to reach Africa—and they do so with astonishing precision. Aided by new ...

Initial favorable safety profile demonstrated in OPGx-BEST1 clinical trialRESEARCH TRIANGLE PARK, N.C., Dec. 09, 2025 (GLOBE ...

Disease development is often shaped by genetics, with how much or how little a gene is expressed influencing disease risk.

Different teams need to make the same conclusion multiple times before a consensus is reached and the finding can be built ...

Researchers at North Carolina State University have developed a new suite of statistical methods that dramatically improves ...

The rapid expansion of high-throughput sequencing technologies has generated unprecedented amounts of multi-omics data, ...

Tenaya Therapeutics remains pre-revenues, and it’s a thinly traded microcap. Its tight cash runway is also a concern. Read ...

Over the past few decades, advances in hematology have illuminated how a delicate balance between stem cell self-renewal and ...

This month Genome Research publishes a special issue highlighting novel advances in computational biology. In collaboration ...